National Bank of Canada’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
50,926
-4,378
| -8% | -$958K | 0.01% | 619 |
|
|
2025
Q1 | $12.4M | Buy |
55,304
+20,805
| +60% | +$4.66M | 0.01% | 550 |
|
|
2024
Q4 | $11.3M | Sell |
34,499
-2,772
| -7% | -$908K | 0.01% | 563 |
|
|
2024
Q3 | $11.2M | Buy |
37,271
+3,012
| +9% | +$904K | 0.01% | 545 |
|
|
2024
Q2 | $11.1M | Buy |
34,259
+2,828
| +9% | +$918K | 0.02% | 469 |
|
|
2024
Q1 | $11.4M | Sell |
31,431
-10,426
| -25% | -$3.8M | 0.02% | 485 |
|
|
2023
Q4 | $14.5M | Sell |
41,857
-10,727
| -20% | -$3.71M | 0.02% | 415 |
|
|
2023
Q3 | $19.6M | Buy |
52,584
+17,396
| +49% | +$6.49M | 0.03% | 337 |
|
|
2023
Q2 | $13.2M | Buy |
35,188
+30,067
| +587% | +$11.3M | 0.02% | 417 |
|
|
2023
Q1 | $1.77M | Buy |
5,121
+911
| +22% | +$316K | ﹤0.01% | 803 |
|
|
2022
Q4 | $991K | Buy |
4,210
+1,485
| +54% | +$349K | ﹤0.01% | 981 |
|
|
2022
Q3 | $694K | Buy |
2,725
+162
| +6% | +$41.3K | ﹤0.01% | 954 |
|
|
2022
Q2 | $787K | Sell |
2,563
-3,075
| -55% | -$944K | ﹤0.01% | 924 |
|
|
2022
Q1 | $2.23M | Sell |
5,638
-17,745
| -76% | -$7.01M | 0.01% | 693 |
|
|
2021
Q4 | $10.9M | Buy |
+23,383
| New | +$10.9M | 0.04% | 314 |
|